Search Results

Can Carvykti Meet Expectations?

• Authors : ISKOWITZ, MARC

Subjects: *TURNAROUND time; *MEDICAL care; *MARKETING

• Source: Medical Marketing & Media. May2024, Vol. 59 Issue 3, p20-21. 2p.

Record details

Cancer cell therapy from Arcellx, Gilead shows promise in early data.

• Authors : Gardner, Jonathan (AUTHOR)

Subjects: *HEALTH facilities; *STOCK prices; MULTIPLE myeloma

• Source: BioPharma Dive. 11/5/2024, pN.PAG-N.PAG. 1p.

Record details

CAR-T therapy for multiple myeloma is on the horizon: Bispecific antibody therapies are also in development.

• Authors : SUTHERBY, ROSANNA¹

Subjects: BISPECIFIC antibodies; MULTIPLE myeloma; CELL receptors

• Source: Managed Healthcare Executive. Jul2022, Vol. 32 Issue 7, p18-18. 1p.

Record details

Multiple myeloma treatment advances: Genome project could lead to a more targeted approach.

• Authors : WALKER, TRACEY¹

Subjects: MULTIPLE myeloma; MULTIPLE myeloma treatment; HEALTH policyMORGAN, Gareth

• Source: Managed Healthcare Executive. Jun2017, Vol. 27 Issue 6, p40-41. 2p.

Record details

J&J secures EMA backing for earlier CAR-T use in multiple myeloma.

• Authors : Pagliarulo, Ned

Subjects: MULTIPLE myeloma; CELLULAR therapyJOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ; EUROPEAN Commission ; BRISTOL-Myers Squibb Co. 001288497 BRISTOL-Myers Squibb Co. BRISTOL-Myers Squibb Co. 001288497 001288497 BRISTOL-Myers Squibb Co. 001288497 BMY

• Source: BioPharma Dive. 2/23/2024, pN.PAG-N.PAG. 1p.

Record details

Struggling 2Seventy scraps a key cancer study.

• Authors : Bell, Jacob (AUTHOR)

Subjects: *CASH & cash equivalents; MULTIPLE myeloma; STEM cell transplantationJOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ

• Source: BioPharma Dive. 9/25/2024, pN.PAG-N.PAG. 1p.

Record details

Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma.

• Authors : Alhamadani, Feryal¹; Chamberlin, Kevin W.²

Subjects: MULTIPLE myeloma; COUGH; ADULTS

• Source: Drug Topics. Jan/Feb2024, Vol. 168 Issue 1, p30-30. 1p.

Record details

J&J wins approval for myeloma treatment.

Subjects: MULTIPLE myeloma; BORTEZOMIB; THERAPEUTICS

• Source: Chain Drug Review. 8/19/2024, Vol. 46 Issue 10, p101-101. 1/5p.

Record details

CHINA APPROVES KYPROLIS FOR R/R MULTIPLE MYELOMA.

Subjects: MULTIPLE myelomaCHINA

• Source: Worldwide Biotech. Aug2021, Vol. 33 Issue 8, pN.PAG-N.PAG. 1p.

Record details

Holding CAR - T cell therapiesto a higher standard with ddPCR.

Subjects: T cells; MULTIPLE myeloma

• Source: Manufacturing Chemist. Jun2022, Vol. 93 Issue 6, p26-28. 3p.

Record details